Biomed-Lublin aims first batch of Covid drug trials in October
21:03
Biomed-Lublin plans to donate the first batch of Covid-19 drug for research clinical trials at the end of October, Piotr Fic, a board member, has announced.
At the beginning of September, the number of ampoules of the drug that can be produced from the collected plasma will be known.
The company would like to produce approx. 3,000 ampoules.
(PAP)
